| A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. |
32409115 |
Eur Urol |
| A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. |
26844274 |
EBioMedicine |
| A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges. |
31013716 |
Int J Mol Sci |
| A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy. |
32945736 |
J Urol |
| African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer. |
32930425 |
Int J Cancer |
| Analysis of <i>PMEPA1</i> Isoforms (<i>a</i> and <i>b</i>) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. |
31842254 |
Cancers (Basel) |
| Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods. |
25889691 |
J Transl Med |
| Association of germline genetic variants with <i>TMPRSS2-ERG</i> fusion status in prostate cancer. |
32341752 |
Oncotarget |
| Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. |
28191285 |
Genes Cancer |
| Clinical potential of the ERG oncoprotein in prostate cancer. |
22331093 |
Nat Rev Urol |
| Contemporary Management of Hemorrhage After Minimally Invasive Radical Prostatectomy. |
31034916 |
Urology |
| Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer. |
33583697 |
Urol Oncol |
| Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer. |
22950997 |
Urology |
| Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy. Reply. |
33591802 |
J Urol |
| ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity. |
25170998 |
Monoclon Antib Immunodiagn Immunother |
| ERG oncoprotein expression in prostate carcinoma patients of different ethnicities. |
25469265 |
Mol Clin Oncol |
| ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. |
25344575 |
Mol Cancer Res |
| ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies. |
22231490 |
Prostate Cancer Prostatic Dis |
| Ethnicity and ERG frequency in prostate cancer. |
28872154 |
Nat Rev Urol |
| Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. |
15613711 |
Clin Chem |
| Evolution in technique of robotic intracorporeal continent catheterizable pouch after cystectomy. |
31893282 |
Urol Video J |
| Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer. |
25221645 |
Genes Cancer |
| Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men. |
23892597 |
Int J Mol Sci |
| Impact of caregiver overnight stay on postoperative outcomes. |
31940152 |
Int J Health Care Qual Assur |
| Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos. |
24909781 |
Prostate |
| Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population. |
30542053 |
Prostate Cancer Prostatic Dis |
| Isolated urethral metastasis from appendiceal mucinous adenocarcinoma. |
32526660 |
Clin Imaging |
| Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India. |
23901346 |
J Cancer |
| Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies <i>ERG</i> as the strongest independent predictor of recurrence. |
31741711 |
Oncotarget |
| Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer. |
31910880 |
J Transl Med |
| Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsy. |
31793867 |
Can Urol Assoc J |
| Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24. |
34127801 |
Prostate Cancer Prostatic Dis |
| Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine. |
34129457 |
Can J Urol |
| Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort. |
28753864 |
Eur Urol Focus |
| Predominance of ERG-negative high-grade prostate cancers in African American men. |
25279185 |
Mol Clin Oncol |
| Prognostic features of Annexin A2 expression in prostate cancer. |
32967771 |
Pathology |
| Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression. |
32429558 |
Cancers (Basel) |
| Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. |
33473200 |
Nat Genet |
| Reply to Benjamin S. Simpson, Lina M. Carmona Echeverria, Joseph M. Norris, Hashim U. Ahmed, Caroline M. Moore, and Hayley C. Whitaker's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magne |
32522388 |
Eur Urol |
| Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men |
32386781 |
Eur Urol |
| Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. |
31874726 |
Eur Urol |
| SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. |
18024530 |
Clin Chem |
| Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node Dissection. |
33997822 |
Eur Urol Open Sci |
| Standardizing Opioid Prescriptions to Patients After Ambulatory Oncologic Surgery Reduces Overprescription. |
32499083 |
Jt Comm J Qual Patient Saf |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. |
33398198 |
Nat Genet |
